Antiallergic Effects of Technologically Processed Antibodies to MHC II
Antiallergic Effects of Technologically Processed Antibodies to MHC II
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
The risk of developing anaphylactic reactions to medications introduces additional difficulties for effective pharmacotherapy. Using a model of systemic anaphylaxis in mice, we showed that preventive administration of a preparation containing technologically processed antibodies (TPA) to MHC II induces an anti-anaphylactic effect comparable to that...
Alternative Titles
Full title
Antiallergic Effects of Technologically Processed Antibodies to MHC II
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2891757714
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2891757714
Other Identifiers
ISSN
0007-4888
E-ISSN
1573-8221
DOI
10.1007/s10517-023-05950-8
